Lv44
624 积分 2021-03-19 加入
BHV-8000, a Selective Brain-penetrant TYK2/JAK1 Inhibitor in Development for Neuroinflammatory and Neurodegenerative Diseases, Demonstrates Efficacy in an Alpha-Synuclein Overexpressing Parkinson’s Disease Mouse Model (S4.006)
3小时前
求助中
Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis
8天前
已完结
ArfGAP2 promotes STING proton channel activity, cytokine transit, and autoinflammation
1个月前
已完结
A Phase I Study to Evaluate the Safety and Pharmacokinetics of SHR0302 Base Ointment in Healthy Adult Volunteers
1个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
1个月前
已完结
Discovery of ABBV-3373, an Anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody Drug Conjugate
2个月前
已完结
Discovery of (S)-1-((2′,6-Bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic Pain
2个月前
已完结
Generative AI: driving productivity and scientific breakthroughs in pharmaceutical R&D
2个月前
已完结
Oral Muvalaplin for Lowering of Lipoprotein(a)
2个月前
已完结
TYK2: an emerging therapeutic target in rheumatic disease
2个月前
已完结
皖公网安备34019202002308
